| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Thomas R Easterling | |
| P2860 | cites work | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy | Q46150310 |
| Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study | Q46743429 | ||
| Maternal central hemodynamics in hypertensive disorders of pregnancy. | Q54071183 | ||
| Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients | Q62538228 | ||
| The effect of maternal hemodynamics on fetal growth in hypertensive pregnancies | Q68058842 | ||
| Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia | Q68058857 | ||
| Oral nifedipine pharmacokinetics in pregnancy-induced hypertension | Q68161837 | ||
| Labetalol pharmacokinetics in pregnancy-induced hypertension | Q68721341 | ||
| Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring | Q69935798 | ||
| Plasma concentration-effect relationship of metoprolol during and after pregnancy | Q70709945 | ||
| Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis | Q73449672 | ||
| Induction of CYP2D6 in pregnancy | Q73846474 | ||
| Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension | Q74061030 | ||
| Atenolol and fetal growth in pregnancies complicated by hypertension | Q77889777 | ||
| Maternal hemodynamic changes associated with furosemide treatment | Q80238093 | ||
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
| Antihypertensive drug therapy for mild to moderate hypertension during pregnancy | Q24200520 | ||
| Pharmacodynamics of Clonidine Therapy in Pregnancy: A Heterogeneous Maternal Response Impacts Fetal Growth | Q28743910 | ||
| Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic | Q33688800 | ||
| CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance | Q34127914 | ||
| Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth | Q34351273 | ||
| Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy | Q34379583 | ||
| Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. | Q34480284 | ||
| β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study | Q36107986 | ||
| Clonidine pharmacokinetics in pregnancy | Q37188050 | ||
| Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | Q38075335 | ||
| Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study | Q41209508 | ||
| Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum | Q45188816 | ||
| P433 | issue | 8 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 487-495 | |
| P577 | publication date | 2014-10-11 | |
| P1433 | published in | Seminars in Perinatology | Q15763431 |
| P1476 | title | Pharmacological management of hypertension in pregnancy. | |
| P478 | volume | 38 |
| Q47861194 | A trial of oral nifedipine and oral labetalol in preeclampsia hypertensive emergency treatment |
| Q57283584 | Adrb2 controls glucose homeostasis by developmental regulation of pancreatic islet vasculature |
| Q38807014 | Antihypertensive Therapy in Females: A Clinical Review Across the Lifespan |
| Q38382465 | Comparison of serum zinc, calcium, and magnesium concentrations in women with pregnancy-induced hypertension and healthy pregnant women: A meta-analysis |
| Q38806961 | Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question). |
| Q50075248 | Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011. |
| Q38369639 | Prevention and management of stroke in women. |
| Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
| Q38540888 | Treating Hypertension in Pregnancy |
| Q47141505 | Uncovering the Pharmacological Mechanism of Astragalus Salvia Compound on Pregnancy-Induced Hypertension Syndrome by a Network Pharmacology Approach |
Search more.